A modified grading system for post-hepatectomy metastatic liver cancer originating from colorectal carcinoma

Journal of Surgical Oncology

Volumn 98, Issue 5, 2008, Pages 363-370

  Nanashima, Atsushi ^a   Sumida, Yorihisa ^a   Abo, Takafumi ^a   Tobinaga, Syuuichi ^a   Takeshita, Hiroaki ^a   Hidaka, Shigekazu ^a   Yasutake, Toru ^a   Nagayasu, Takeshi ^a   Mine, Mariko ^a   Sawai, Terumitsu ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Clinical risk score; Colon cancer; Grading system; Metastatic liver cancer; Prognosis

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CARCINOMA; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; JAPANESE; LIVER CANCER; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 53549122244     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21114     Document Type: Article

References (42)

1. Gorog D, Toth A, Weltner J: Prognosis of untreated liver metastasis from rectal cancer. Acta Chir Hung 1997;36:106-107.
2. Fong Y, Blumgart LH: Hepatic colorectal metastasis: Current status of surgical therapy. Oncology 1998;12:1489-1498.
3. Scheele J, Stang R, Altendorf-Hofmann A, et al.: Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
4. Jaeck D, Bachellier P, Guiguet M, et al.: Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 1997;84:977-980.
5. Stangl R, Altendorf-Hofmann A, Charnley RM, et al.: Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-1410.
6. Nordlinger B, Guiguet M, Vaillant JC, et al.: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254-1262.
7. Fong Y, Fortner J, Sun RL: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309-318.
8. Rodgers MS, McCall JL: Surgery for colorectal liver metastases with hepatic lymph node involvement: A systematic review. Br J Surg 2000;87:1142-1155.
9. Foster JH: Survival after liver resection for secondary tumors. Am J Surg 1978;135:389-394.
10. Fortner JG, Silva JS, Golbey RB, et al.: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984;199:306-316.
11. Butler J, Attiyeh FF, Daly JM: Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 1986;162:109-113.
12. Iwatsuki S, Esquivel CO, Gordon RD, et al.: Liver resection for metastatic colorectal cancer. Surgery 1986;100:804-810.
13. Doci R, Gennari L, Bignami P, et al.: One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 1991;78:797-801.
14. Gayowski TJ, Iwatsuki S, Madariaga JR, et al.: Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 1994;116:703-710.
15. Jamison RL, Donohue JH, Nagorney DM, et al.: Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132:505-510.
16. Bakalakos EA, Kim JA, Young DC, et al.: Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 1998;22:399-404.
17. Cady B, Jenkins RL, Steele GD, Jr., et al.: Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome. Ann Surg 1998;227:566-571.
18. Jarnagin WR, Conlon K, Bodniewicz J, et al.: A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 2001;91:1121-1128.
19. Aldrighetti L, Castoldi R, Di Palo S, et al.: Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases. Chir Ital 2005;57:555-570.
20. Minagawa M, Makuuchi M, Torzilli G, et al.: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: Long-term results. Ann Surg 2000;231:487-499.
21. Choti MA, Sitzmann JV, Tiburi MF, et al.: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-766.
22. Minagawa M, Yamamoto J, Kosuge T, et al.: Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: Development and validation. Arch Surg 2007;142:269-276.
23. Nagashima I, Takada T, Matsuda K, et al.: A new scoring system to classify patients with colorectal liver metastases: Proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 2004;11:79-83.
24. Japanese Research Society for Cancer of the Colon and Rectum. In: Yasutomi M, editor. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 5th edition. Tokyo: Kanehara Co., Ltd; 1994; 11.
25. Japanese Society for Cancer of the Colon and Rectum. Liver metastasis. In: Yasutomi M, editor. Japanese classification of colorectal carcinoma. First English edition. Tokyo: Kanehara Co., Ltd; 1997; 18.
26. Nanashima A, Yamaguchi H, Sawai T, et al.: Prognostic factors in hepatic metastases of colorectal carcinoma: Immunohistochemical analysis of tumor biological factors. Dig Dis Sci 2001;46:1623-1628.
27. Ueno H, Mochizuki H, Hatsuse K, et al.: Indicators for treatment strategies of colorectal liver metastases. Ann Surg 2000;231:59-66.
28. Japanese Society for Cancer of the Colon and Rectum. In: Mutoh T, editor. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. (in Japanese). 7th edition. Tokyo: Kanehara Co., Ltd; 2006; pp. 14-15.
29. Fretz CJ, Stark DD, Metz CE, et al.: Detection of hepatic metastases: Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. Am J Roentgenol 1990;155:763-770.
30. Saunders MP, Hogg M, Carrington B, et al.: Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer. Br J Cancer 2004;91:1447-1452.
31. Akaike H: A new look at the statistical model identification. IEEE Trans Automatic Control 1974;AC-19:716-723.
32. Kokudo N, Imamura H, Sugawara Y, et al.: Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 2004;11:84-91.
33. Curley SA, Izzo F, Abdalla E, et al.: Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev 2004;23:165-182.
34. Liu LX, Zhang WH, Jiang HC: Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 2003;9:193-200.
35. Tanaka K, Shimada H, Nagano Y, et al.: Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 2006;139:263-273.
36. Abdalla EK, Vauthey JN, Ellis LM, et al.: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-825.
37. Kato T, Yasui K, Hirai T, et al.: Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: Analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 2003;46:S22-S31.
38. Tanaka K, Shimada H, Matsuo K, et al.: Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004;136:650-659.
39. Cillo U, Vitale A, Grigoletto F, et al.: Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006;44:723-731.
40. Kudo M, Chung H, Haji S, et al.: Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score. Hepatology 2004;40:1396-1405.
41. Nanashima A, Sumida Y, Abo T, et al.: Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy. J Gastroenterol 2006;41:250-256.
42. Fernandez FG, Drebin JA, Linehan DC, et al.: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-447.